Eli Lilly Acquires CrossBridge Bio for ~$300M, Accelerating Its Next-Generation ADC Oncology Strategy
https://oncodaily.com/techology/crossbridge-bio486815?utm_source=OM&utm_medium=email&utm_campaign=N041826
https://oncodaily.com/techology/crossbridge-bio486815?utm_source=OM&utm_medium=email&utm_campaign=N041826
OncoDaily
Eli Lilly Acquires CrossBridge Bio for ~$300M, Accelerating Its Next-Generation ADC Oncology Strategy
Eli Lilly has announced the acquisition of CrossBridge Bio for approximately $300 million, securing access to a differentiated next-generation ADC platform as the company aggressively expands its oncology pipeline beyond tirzepatide.
❤1
Zoldonrasib Shows Early Strength in Previously Treated KRAS G12D NSCLC
https://oncodaily.com/oncolibrary/lung-oncology/zoldonrasib?utm_source=OM&utm_medium=email&utm_campaign=N042026
https://oncodaily.com/oncolibrary/lung-oncology/zoldonrasib?utm_source=OM&utm_medium=email&utm_campaign=N042026
OncoDaily
Zoldonrasib Shows Early Strength in Previously Treated KRAS G12D NSCLC
Revolution Medicines zoldonrasib data in KRAS G12D NSCLC showed 52% ORR and 11.1-month PFS in previously treated patients at AACR 2026.
❤1
Eli Lilly Acquires Kelonia Therapeutics for Up to $7B, Making Bold Entry Into In Vivo CAR-T Cell Therapy
https://oncodaily.com/techology/kelonia-487928?utm_source=OM&utm_medium=email&utm_campaign=N042026
https://oncodaily.com/techology/kelonia-487928?utm_source=OM&utm_medium=email&utm_campaign=N042026
OncoDaily
Eli Lilly Acquires Kelonia Therapeutics for Up to $7B, Making Bold Entry Into In Vivo CAR-T Cell Therapy
Eli Lilly Acquires Kelonia Therapeutics for Up to $7B, Making Bold Entry Into In Vivo CAR-T Cell Therapy / Headlines
❤1
Oncology Biotech Weekly: $6B Deals, Personalized Cancer Vaccines & Liquid Biopsy Breakthroughs
https://oncodaily.com/techology/biotech486813?utm_source=OM&utm_medium=email&utm_campaign=N042026
https://oncodaily.com/techology/biotech486813?utm_source=OM&utm_medium=email&utm_campaign=N042026
OncoDaily
Oncology Biotech Weekly: $6B Deals, Personalized Cancer Vaccines & Liquid Biopsy Breakthroughs
Oncology biotech this week: $6B+ in deals, Revolution Medicines’ $2B financing, and personalized cancer vaccines showing 11/14 patients cancer-free at 6 years.
❤2
innovaTV Trial Update: Tisotumab Vedotin in Cervical Cancer
https://oncodaily.com/industry/innovatv-205?utm_source=OM&utm_medium=email&utm_campaign=N042026
https://oncodaily.com/industry/innovatv-205?utm_source=OM&utm_medium=email&utm_campaign=N042026
OncoDaily
innovaTV Trial Update: Tisotumab Vedotin in Cervical Cancer
Trial update from innovaTV 205/ENGOT-cx8/GOG-3024 evaluating tisotumab vedotin combined with carboplatin or pembrolizumab in recurrent or metastatic cervical cancer, highlighting durable responses and long-term clinical outcomes.
❤1
Miles to Go Before We Sleep — Dr. Richard Goldberg on Curing Colorectal Cancer
https://oncodaily.com/dialogues/richard-goldberg-colorectal-cancer490949?utm_source=OM&utm_medium=email&utm_campaign=N042526
https://oncodaily.com/dialogues/richard-goldberg-colorectal-cancer490949?utm_source=OM&utm_medium=email&utm_campaign=N042526
OncoDaily
Miles to Go Before We Sleep — Dr. Richard Goldberg on Curing Colorectal Cancer
Miles to Go Before We Sleep — Dr. Richard Goldberg on Curing Colorectal Cancer / colorectal cancer, immunotherapy, OncoDaily, Richard Goldberg
❤1
OncoDiscovery Award – A New Short-Term Funding Opportunity for Early-Career Medical Oncologists Around the World
https://oncodaily.com/pulse/oncodiscovery-488762?utm_source=OM&utm_medium=email&utm_campaign=N042526
https://oncodaily.com/pulse/oncodiscovery-488762?utm_source=OM&utm_medium=email&utm_campaign=N042526
OncoDaily
OncoDiscovery Award – A New Short-Term Funding Opportunity for Early-Career Medical Oncologists Around the World
OncoDiscovery Award - A New Short-Term Funding Opportunity for Early-Career Medical Oncologists Around the World / cancer, drug discovery, Early Drug
❤1
Issue #114 Is Live – Exploring What Progress in Oncology Really Means – CancerWorld
https://oncodaily.com/voices/cancerworld-488738?utm_source=OM&utm_medium=email&utm_campaign=N042526
https://oncodaily.com/voices/cancerworld-488738?utm_source=OM&utm_medium=email&utm_campaign=N042526
OncoDaily
Issue #114 Is Live – Exploring What Progress in Oncology Really Means – CancerWorld
Issue #114 Is Live - Exploring What Progress in Oncology Really Means - CancerWorld / cancer, Cancerworld, OncoDaily, Oncology
❤1
Alberto Costa on a 45-Year Journey and Future Direction – European School of Oncology
https://oncodaily.com/voices/alberto-costa-489584?utm_source=OM&utm_medium=email&utm_campaign=N042526
https://oncodaily.com/voices/alberto-costa-489584?utm_source=OM&utm_medium=email&utm_campaign=N042526
OncoDaily
Alberto Costa on a 45-Year Journey and Future Direction – European School of Oncology
Alberto Costa on a 45-Year Journey and Future Direction - European School of Oncology / Alberto Costa, cancer, eso, European School of Oncology, OncoDaily,
❤1
A new partnership to take cancer vaccines from research to care – with Karen Knudsen and Kristen Dahlgren
https://oncodaily.com/opinion/489046-cancer-vaccines?utm_source=OM&utm_medium=email&utm_campaign=N042526
https://oncodaily.com/opinion/489046-cancer-vaccines?utm_source=OM&utm_medium=email&utm_campaign=N042526
OncoDaily
A new partnership to take cancer vaccines from research to care – with Karen Knudsen and Kristen Dahlgren
A new partnership to take cancer vaccines from research to care - with Karen Knudsen and Kristen Dahlgren / cancer immunotherapy, cancer recurrence
❤1
Top Immunotherapy Trials to Watch at ASCO 2026
https://oncodaily.com/oncolibrary/immune-oncology/asco-2026-io?utm_source=OM&utm_medium=email&utm_campaign=N042526
https://oncodaily.com/oncolibrary/immune-oncology/asco-2026-io?utm_source=OM&utm_medium=email&utm_campaign=N042526
OncoDaily
Top Immunotherapy Trials to Watch at ASCO 2026
A curated preview of the most important immunotherapy trials to watch at the ASCO 2026 Annual Meeting, highlighting innovative strategies across melanoma, urothelial, pancreatic, and HPV-associated cancers.
❤1
A Systems Failure in Medicine at War Zones but We Know What to Do – OncoCorridor
https://oncodaily.com/voices/cancerworld-490690?utm_source=OM&utm_medium=email&utm_campaign=N042626
https://oncodaily.com/voices/cancerworld-490690?utm_source=OM&utm_medium=email&utm_campaign=N042626
OncoDaily
A Systems Failure in Medicine at War Zones but We Know What to Do – OncoCorridor
A Systems Failure in Medicine at War Zones but We Know What to Do - OncoCorridor / cancer, Cancerworld, Gevorg Tamamyan, OncoCorridor, OncoDaily, Oncology
❤1
ASCO Announces 2026–2027 Leadership Development Program Cohort
https://oncodaily.com/career/asco-2026-2027?utm_source=OM&utm_medium=email&utm_campaign=N042626
https://oncodaily.com/career/asco-2026-2027?utm_source=OM&utm_medium=email&utm_campaign=N042626
Oncodaily - Oncology News, Insights, Stories
ASCO Announces 2026–2027 Leadership Development Program Cohort - OncoDaily
ASCO Announces 2026–2027 Leadership Development Program Cohort / Abdul Rafeh Naqash, Abirami Sivapiragasam, Alvaro Menendez, Ana C. Garrido-Castro, Andrea
❤1
Margaret Foti and AACR Delegates Thank Congress for Protecting NIH/NCI Funding
https://oncodaily.com/voices/aacr-488206?utm_source=OM&utm_medium=email&utm_campaign=N042526
https://oncodaily.com/voices/aacr-488206?utm_source=OM&utm_medium=email&utm_campaign=N042526
OncoDaily
Margaret Foti and AACR Delegates Thank Congress for Protecting NIH/NCI Funding
AACR
❤1
Tania Small Receives ACS Humanitarian Award 2026
https://oncodaily.com/career/tania-small-acs?utm_source=OM&utm_medium=email&utm_campaign=N042626
https://oncodaily.com/career/tania-small-acs?utm_source=OM&utm_medium=email&utm_campaign=N042626
OncoDaily
Tania Small Receives ACS Humanitarian Award 2026
Tania Small Receives ACS Humanitarian Award 2026 / ACS, American Cancer Society, cancer, Headlines, Humanitarian Award, OncoDaily, Oncology, Tania Small
❤2
FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access
https://oncodaily.com/fda-approvals/daraxonrasib-495412?utm_source=OM&utm_medium=email&utm_campaign=N050326
https://oncodaily.com/fda-approvals/daraxonrasib-495412?utm_source=OM&utm_medium=email&utm_campaign=N050326
OncoDaily
FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access
Daraxonrasib
❤1
OncoBillionaires 2026: 28 Billionaires Powering Innovation and Access Challenges
https://oncodaily.com/industry/oncobillionaires-2026?utm_source=OM&utm_medium=email&utm_campaign=N050326
https://oncodaily.com/industry/oncobillionaires-2026?utm_source=OM&utm_medium=email&utm_campaign=N050326
OncoDaily
OncoBillionaires 2026: 28 Billionaires Powering Innovation and Access Challenges
OncoBillionaires 2026 from Forbes 2026 Billionaires List,
❤2
Gedatolisib in VIKTORIA-1: Positive Topline Data in PIK3CA-Mutant Metastatic Breast Cancer
https://oncodaily.com/oncolibrary/breast-oncology/viktoria-1-2?utm_source=OM&utm_medium=email&utm_campaign=N050326
https://oncodaily.com/oncolibrary/breast-oncology/viktoria-1-2?utm_source=OM&utm_medium=email&utm_campaign=N050326
OncoDaily
Gedatolisib in VIKTORIA-1: Positive Topline Data in PIK3CA-Mutant Metastatic Breast Cancer
Gedatolisib VIKTORIA-1 shows improved PFS in PIK3CA breast cancer after CDK4/6 progression; full ASCO 2026 data awaited.
❤1
Charles Swanton: How Does Lung Cancer Actually Spread?
https://oncodaily.com/voices/charles-swanton-495302?utm_source=OM&utm_medium=email&utm_campaign=N050326
https://oncodaily.com/voices/charles-swanton-495302?utm_source=OM&utm_medium=email&utm_campaign=N050326
OncoDaily
Charles Swanton: How Does Lung Cancer Actually Spread?
Charles Swanton
❤1
$70 Million Guinness World Record Livestream: How Łatwogang Changed Cancer Philanthropy
https://oncodaily.com/stories/celebrities/latwogang-70-million-livestream?utm_source=OM&utm_medium=email&utm_campaign=N050126
https://oncodaily.com/stories/celebrities/latwogang-70-million-livestream?utm_source=OM&utm_medium=email&utm_campaign=N050126
OncoDaily
$70 Million Guinness World Record Livestream: How Łatwogang Changed Cancer Philanthropy
$70 Million Guinness World Record Livestream: How Łatwogang Changed Cancer Philanthropy / atwogang, cancer, cancer awareness, Cancer Charity, cancer fighters,
❤1